SNIPR BIOME raised EUR 35M in Series B funding led by Cystic Fibrosis Foundation and SPRIN-D to develop a CRISPR-Cas therapy for airway infections in cystic fibrosis patients.
Amount Raised
€35 Million
Round Type
Series B
CopenhagenBiotechnologyHealth CareInvestors
Description
SNIPR BIOME, based in Copenhagen, Denmark, secured EUR 35M in Series B funding to enhance microbial CRISPR-medicine development. The funding will support a targeted CRISPR-Cas therapy for treating infections caused by Pseudomonas aeruginosa in cystic fibrosis patients. Backers include the Cystic Fibrosis Foundation and the German Federal Agency for Breakthrough Innovation along with existing investors. Led by CEO Christian Grøndahl, the company employs innovative CRISPR-Cas technology.
Quick answer
SNIPR Biome raised €35 Million in a Series B round, dated August 7, 2025. Investors: Lundbeckfonden BioCapital, North-East Family Office, German Federal Agency For Breakthrough Innovation, Wellington Partners and Cystic Fibrosis Foundation. SNIPR Biome is based in Copenhagen, Capital Region Of Denmark, Denmark.
- How much did SNIPR Biome raise?
- SNIPR Biome raised €35 Million in a Series B round on August 7, 2025.
- Who invested in SNIPR Biome?
- Lundbeckfonden BioCapital, North-East Family Office, German Federal Agency For Breakthrough Innovation, Wellington Partners and Cystic Fibrosis Foundation are named as investors in this round.
- What does SNIPR Biome do?
- SNIPR BIOME is a Danish clinical-stage biotech company focused on improving microbial CRISPR-medicine.
- Where is SNIPR Biome based and how big is it?
- SNIPR Biome is based in Copenhagen, Capital Region Of Denmark, Denmark. Fundz records about 41 employees.
- Who are the decision-makers at SNIPR Biome?
- Fundz holds 1 contact at SNIPR Biome. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as SNIPR Biome that raised within 45 days of this round, from Fundz verified event records.
- FOXO Technologies raised $600K on September 19, 2025.
- Revive Therapeutics raised $91K (Post-IPO Equity) on September 19, 2025.
- MoldCo raised $8M (Seed) on September 18, 2025.
- iVeena raised $2M (Grant) on September 18, 2025.
- ARTHEx Biotech raised $87M (Series B) on September 17, 2025.
- Osheru raised $4.8M (Seed) on September 17, 2025.
Who to call at SNIPR Biome, and when
A new round usually means SNIPR Biome is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day SNIPR Biome raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SNIPR Biome, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SNIPR Biome. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SNIPR Biome raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSNIPR Biome raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.